Frontline Science: Characterization of a novel mouse strain expressing human Siglec-8 only on eosinophils

Jeremy A. O'Sullivan, Yadong Wei, Daniela J. Carroll, Liliana Moreno-Vinasco, Yun Cao, Fengrui Zhang, James J. Lee, Zhou Zhu, Bruce S. Bochner

Research output: Contribution to journalArticlepeer-review

15 Scopus citations


Sialic acid-binding immunoglobulin-like lectin (Siglec)-8 is a human cell surface protein expressed exclusively on eosinophils, mast cells, and basophils that, when engaged, induces eosinophil apoptosis and inhibits mast cell mediator release. This makes Siglec-8 a promising therapeutic target to treat diseases involving these cell types. However, preclinical studies of Siglec-8 targeting in vivo are lacking because this protein is only found in humans, apes, and some monkeys. Therefore, we have developed a mouse strain in which SIGLEC8 transcription is activated by Cre recombinase and have crossed this mouse with the eoCre mouse to achieve eosinophil-specific expression. We confirmed that Siglec-8 is expressed exclusively on the surface of mature eosinophils in multiple tissues at levels comparable to those on human blood eosinophils. Following ovalbumin sensitization and airway challenge, Siglec-8 knock-in mice generated a pattern of allergic lung inflammation indistinguishable from that of littermate controls, suggesting that Siglec-8 expression within the eosinophil compartment does not alter allergic eosinophilic inflammation. Using bone marrow from these mice, we demonstrated that, during maturation, Siglec-8 expression occurs well before the late eosinophil developmental marker C-C motif chemokine receptor 3, consistent with eoCre expression. Antibody ligation of the receptor induces Siglec-8 endocytosis and alters the phosphotyrosine profile of these cells, indicative of productive signaling. Finally, we demonstrated that mouse eosinophils expressing Siglec-8 undergo cell death when the receptor is engaged, further evidence that Siglec-8 is functional on these cells. These mice should prove useful to investigate Siglec-8 biology and targeting in vivo in a variety of eosinophilic disease models.

Original languageEnglish (US)
Pages (from-to)11-19
Number of pages9
JournalJournal of Leukocyte Biology
Issue number1
StatePublished - Jul 2018


  • Siglec-F
  • Transgenic
  • apoptosis
  • asthma
  • knock-in
  • pre-clinical

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Cell Biology


Dive into the research topics of 'Frontline Science: Characterization of a novel mouse strain expressing human Siglec-8 only on eosinophils'. Together they form a unique fingerprint.

Cite this